These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28420298)

  • 1. Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment.
    Calza L; Colangeli V; Magistrelli E; Rossi N; Rosselli Del Turco E; Bussini L; Borderi M; Viale P
    HIV Clin Trials; 2017 May; 18(3):110-117. PubMed ID: 28420298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
    Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
    Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study.
    Msoka TF; Van Guilder GP; Smulders YM; van Furth M; Bartlett JA; van Agtmael MA
    BMC Infect Dis; 2018 Dec; 18(1):708. PubMed ID: 30594160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy.
    Lombo B; Alkhalil I; Golden MP; Fotjadhi I; Ravi S; Virata M; Lievano M; Diez J; Ghantous A; Donohue T
    Conn Med; 2015 May; 79(5):277-81. PubMed ID: 26245015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia.
    Hirigo AT; Tesfaye DY
    BMC Res Notes; 2016 Mar; 9():145. PubMed ID: 26945987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of highly active antiretroviral therapy associated metabolic abnormalities and lipodystrophy in HIV infected patients.
    Feleke Y; Fekade D; Mezegebu Y
    Ethiop Med J; 2012 Jul; 50(3):221-30. PubMed ID: 23409405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy.
    Hansen BR; Petersen J; Haugaard SB; Madsbad S; Obel N; Suzuki Y; Andersen O
    HIV Med; 2009 Jul; 10(6):378-87. PubMed ID: 19490178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical correlates of metabolic syndrome in Nigerians living with human immunodeficiency virus/acquired immunodeficiency syndrome.
    Ayodele OE; Akinboro AO; Akinyemi SO; Adepeju AA; Akinremi OA; Alao CA; Popoola AA
    Metab Syndr Relat Disord; 2012 Oct; 10(5):373-9. PubMed ID: 22799758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America.
    Alvarez C; Salazar R; Galindez J; Rangel F; Castaãeda ML; Lopardo G; Cuhna CA; Roldan Y; Sussman O; Gutierrez G; Cure-Bolt N; Seas C; Carcamo C; Castrillo M
    Braz J Infect Dis; 2010; 14(3):256-63. PubMed ID: 20835509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome among HIV-infected patients in Ghana: A cross-sectional study.
    Obirikorang C; Quaye L; Osei-Yeboah J; Odame EA; Asare I
    Niger Med J; 2016; 57(2):86-90. PubMed ID: 27226681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patients.
    Gupta V; Biswas A; Sharma SK
    Int J STD AIDS; 2011 Jan; 22(1):46-9. PubMed ID: 21364067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic disorders and cardiovascular risk in people living with HIV/AIDS without the use of antiretroviral therapy.
    Raposo MA; Armiliato GNA; Guimarães NS; Caram CA; Silveira RDS; Tupinambás U
    Rev Soc Bras Med Trop; 2017; 50(5):598-606. PubMed ID: 29160505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.
    Julius H; Basu D; Ricci E; Wing J; Basu JK; Pocaterra D; Bonfanti P
    Curr HIV Res; 2011 Jun; 9(4):247-52. PubMed ID: 21631427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of metabolic syndrome in HIV-infected adults at three urban clinics in a post-conflict setting, eastern Democratic Republic of the Congo.
    Katoto PDMC; Thienemann F; Bulabula ANH; Esterhuizen TM; Murhula AB; Lunjwire PPM; Bihehe DM; Nachega JB
    Trop Med Int Health; 2018 Jul; 23(7):795-805. PubMed ID: 29752857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Syndrome in Children and Adolescents Living with HIV.
    Espiau M; Yeste D; Noguera-Julian A; González-Tomé MI; Falcón-Neyra L; Gavilán C; Navarro-Gómez ML; Mellado-Peña MJ; Gracia-Casanova M; Colino-Gil ME; Méndez M; Ciria Calavia LM; Fortuny C; Carrascosa A; Soler-Palacín P;
    Pediatr Infect Dis J; 2016 Jun; 35(6):e171-6. PubMed ID: 26910591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
    Dave JA; Levitt NS; Ross IL; Lacerda M; Maartens G; Blom D
    PLoS One; 2016; 11(3):e0151911. PubMed ID: 26986065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome among human immunodeficiency virus-infected subjects is widely influenced by the diagnostic criteria.
    Cubero JM; Domingo P; Sambeat M; Ordoñez-Llanos J; Rodriguez-Espinosa J; Sánchez-Quesada JL; Pérez A
    Metab Syndr Relat Disord; 2011 Oct; 9(5):345-51. PubMed ID: 21542770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
    Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.